The elevated expression of hK6 in early-stage and low-grade ovarian tumours may suggest that upregulation of this protein may be an early event during ovarian cancer development and hK6 may have potential use as biomarkers for the early detection of ovarian cancer. Here, KLK6 is linked to ovarian neoplasm.